Oarsman Capital’s MetLife MET Stock Holding History

Oarsman Capital’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-457	Closed	-$37.4K	–	597
2024 Q4	$37.4K	Hold	457	–	–	0.01%	495
2024 Q3	$37.7K	Buy	+457	New	+$34.1K	0.01%	494
2019 Q2	–	Sell	-30,300	Closed	-$1.29M	–	180
2019 Q1	$1.29M	Sell	30,300 -375	-1%	-$16.6K	0.61%	58
2018 Q4	$1.26M	Sell	30,675 -16,125	-34%	-$692K	0.65%	57
2018 Q3	$2.19M	Buy	46,800 +15,625	+50%	+$714K	0.88%	38
2018 Q2	$1.36M	Hold	31,175	–	–	0.62%	58
2018 Q1	$1.43M	Hold	31,175	–	–	0.65%	50
2017 Q4	$1.58M	Sell	31,175 -300	-1%	-$15.8K	0.68%	48
2017 Q3	$1.64M	Sell	31,475 -3,840	-11%	-$187K	0.69%	46
2017 Q2	$1.73M	Sell	35,315 -605	-2%	-$28.1K	0.79%	41
2017 Q1	$1.69M	Sell	35,920 -224	-0.6%	-$10.7K	0.79%	41
2016 Q4	$1.74M	Hold	36,144	–	–	1.12%	28
2016 Q3	$1.43M	Sell	36,144 -17,616	-33%	-$662K	0.73%	43
2016 Q2	$1.91M	Sell	53,760 -364	-0.7%	-$14.2K	0.99%	33
2016 Q1	$2.12M	Buy	54,124 +2,749	+5%	+$103K	1.13%	25
2015 Q4	$2.21M	Buy	51,375 +1,219	+2%	+$53.6K	1.24%	18
2015 Q3	$2.11M	Buy	+50,156	New	+$2.34M	1.25%	19

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Oarsman Capital's MET Position: Q1 2025 in Review

Oarsman Capital sold out of MetLife (MET) in Q1 2025, closing a stake of 457 shares — an estimated $37.4K sold.

Oarsman Capital first reported a position in MET in Q3 2015 and held it in 17 quarters. The position peaked at $2.21M in Q4 2015. 1,411 funds tracked by Wall St. Rank hold MET as of Q1 2025.

Oarsman Capital reported no remaining MetLife position as of Q1 2025 after selling out during the quarter.
Oarsman Capital sold 457 MetLife shares in Q1 2025, an estimated $37.4K.
Oarsman Capital first reported a position in MetLife in Q3 2015 and held it in 17 quarters.
Oarsman Capital's MetLife position peaked at $2.21M in Q4 2015.
1,411 funds tracked by Wall St. Rank held MetLife as of Q1 2025.

Based on Oarsman Capital's 13F filing for Q1 2025, filed 14 May 2025.